These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10155612)

  • 1. Should the philosophy of postmarketing surveillance in the US be redefined?
    Soto J; Sacristan JA
    Pharmacoeconomics; 1995 Aug; 8(2):175-6. PubMed ID: 10155612
    [No Abstract]   [Full Text] [Related]  

  • 2. Postmarketing surveillance of food additives.
    Butchko HH; Tschanz C; Kotsonis FN
    Regul Toxicol Pharmacol; 1994 Aug; 20(1 Pt 1):105-18. PubMed ID: 7838988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Industry reneges on postmarketing trial commitments.
    Bouchie A
    Nat Biotechnol; 2003 Jul; 21(7):718. PubMed ID: 12833074
    [No Abstract]   [Full Text] [Related]  

  • 4. Reforms on drug safety.
    Nature; 2006 Sep; 443(7110):372. PubMed ID: 17006474
    [No Abstract]   [Full Text] [Related]  

  • 5. Postmarketing modifications in the safety labeling of the new antiepileptics.
    Buck ML; Gurka MJ; Goodkin HP
    Neurology; 2007 May; 68(18):1536-7. PubMed ID: 17470758
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacoepidemiology: current status, prospects, and problems.
    Strom BL; Tugwell P
    Ann Intern Med; 1990 Aug; 113(3):179-81. PubMed ID: 2197907
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA's Foray Into Big Data Still Maturing.
    Kuehn BM
    JAMA; 2016 May; 315(18):1934-6. PubMed ID: 27097048
    [No Abstract]   [Full Text] [Related]  

  • 8. Prepare for the long haul of drug monitoring.
    Gliklich R
    Nat Med; 2010 Aug; 16(8):848. PubMed ID: 20689542
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative regulation of drug and aircraft development: lessons for regulatory reform?
    Urquhart J
    Clin Pharmacol Ther; 1997 Dec; 62(6):583-6. PubMed ID: 9433385
    [No Abstract]   [Full Text] [Related]  

  • 10. What you don't know will hurt you.
    Nat Biotechnol; 2008 Jun; 26(6):589. PubMed ID: 18536658
    [No Abstract]   [Full Text] [Related]  

  • 11. StatBite. FDA-required postmarketing studies, 1992-2008.
    J Natl Cancer Inst; 2010 Sep; 102(17):1303. PubMed ID: 20739654
    [No Abstract]   [Full Text] [Related]  

  • 12. The Fidelis recall: how much pressure can the ICD world bear?
    Cannom DS; Fisher J
    Pacing Clin Electrophysiol; 2008 Oct; 31(10):1233-5. PubMed ID: 18811800
    [No Abstract]   [Full Text] [Related]  

  • 13. The FDA and safety--beyond the heparin crisis.
    Laurencin CT; Nair L
    Nat Biotechnol; 2008 Jun; 26(6):621-3. PubMed ID: 18536680
    [No Abstract]   [Full Text] [Related]  

  • 14. Echocardiographer as patient advocate: lessons from the contrast debate.
    Ryan T
    J Am Soc Echocardiogr; 2008 Mar; 21(3):A29. PubMed ID: 18314045
    [No Abstract]   [Full Text] [Related]  

  • 15. Canaries, coal mines and the drug supply.
    Leiden JM
    Nat Biotechnol; 2008 Jun; 26(6):624-6. PubMed ID: 18536681
    [No Abstract]   [Full Text] [Related]  

  • 16. Global shift toward increased biovigilance.
    Vogel L
    CMAJ; 2010 Apr; 182(6):544-6. PubMed ID: 20194564
    [No Abstract]   [Full Text] [Related]  

  • 17. President's Message: contrast echocardiography: moving from controversy to consensus.
    Zoghbi WA
    J Am Soc Echocardiogr; 2008 Sep; 21(9):A25-6. PubMed ID: 18765170
    [No Abstract]   [Full Text] [Related]  

  • 18. The Food and Drug Administration's use of postmarketing (Phase IV) study requirements: exception to the rule?
    Steenburg C
    Food Drug Law J; 2006; 61(2):295-383. PubMed ID: 16903034
    [No Abstract]   [Full Text] [Related]  

  • 19. FDA increases focus on postmarketing studies.
    Goozner M
    J Natl Cancer Inst; 2010 Sep; 102(17):1302-4. PubMed ID: 20739650
    [No Abstract]   [Full Text] [Related]  

  • 20. The future of automated record linkage for postmarketing surveillance: a response to Shapiro.
    Faich GA; Stadel BV
    Clin Pharmacol Ther; 1989 Oct; 46(4):387-9. PubMed ID: 2791441
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.